Antiangiogenicagents

Journal of Clinical Oncology P

12 years ago

Serious Bevacizumab-Associated Gastrointestinal Toxicity

bevacizumab

ovariancancer

gastrointestinaltoxicity

antiangiogenicagents

phase3trials

+5

+4

+4

+4

+3

+3

+3

+3

+2

bevacizumab

ovariancancer

gastrointestinaltoxicity

antiangiogenicagents

phase3trials

+5

+4

+4

+4

+3

+3

+3

+3

+2